Cargando…
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential
Myasthenia gravis (MG) is an autoimmune disease leading to varying degrees of skeletal muscle weakness. It is caused by specific antibodies directed against definite components in the postsynaptic membrane at the neuromuscular junction (NMJ), such as the acetylcholine receptor (AChR) and the muscle-...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740073/ https://www.ncbi.nlm.nih.gov/pubmed/31588250 http://dx.doi.org/10.1177/1849454419875912 |